Aurobindo
Pharma’s efforts to become a comprehensive producer of Cephalosporin therapeutic group of
products received a major boost when its product CEFACTAM got the clearance from the Drug
Controller of India, a few weeks ago. Ever since, Aurobindo Pharma has launched this
formulation brand aggressively and has already penetrated deeply the domestic formulations
market.
CEFACTAM
is a powerful combination of Cefoperazone (a highly potent third generation Cephalosporin) and
Salbactam (a powerful beta-lactamase enzyme inhibitor) which makes it a highly efficient drug
to counter life threatening infectious diseases. |
|
| The
highly successful launch of CEFACTAM has further consolidated Aurobindo Pharma’s already
dominant status as the second largest global producer of Cephalosporins. The continued R&D
thrust is likely to help the Company launch other Cephalosporins. Too like Cefdinir, Cefprozil
and Cefipime, etc. all of which are on the anvil. With these efforts, Aurobindo Pharma expects
a significant addition to its revenue from Cephalosporins in general, and branded formulations
in particular. |
|
PRESS
ROOM 
